Browse studies

Find your next paid study

7 recruiting studies matching your filters

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis)

Researchers are looking for new ways to treat radiographic axial spondyloarthritis (r-axSpA). R-axSpA is a type of arthritis that causes pain, stiffness, and i…

Radiographic Axial Spondyloarthritis

Estimated

~$10 – $8,750

Merck Sharp & Dohme LLCNCT07133633

Observational

Pilot Randomized Controlled Trial of the RENEW Intervention for Axial Spondyloarthritis

The researchers are testing a web-based peer-led program to help manage energy and symptoms in people who have axial spondyloarthritis (axSpA). There are 3 mai…

Axial Spondyloarthritis

Estimated

~$10 – $6,250

University of MichiganNCT07836374

Phase 1

A Multicenter Open-label, Prospective Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.

Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more

Estimated

~$10 – $8,750

UCB Biopharma SRLNCT06888193

Phase 4

A Pragmatic Randomized Pilot Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis

The purpose of this study is to determine the feasibility of conducting a pragmatic trial of IL-17i versus JAKi in adults with axial spondyloarthritis (axSpA) …

Axial Spondyloarthritis (AxSpA)

Estimated

~$10 – $6,250

The University of Texas Health Science Center, HoustonNCT07770646

Phase 1

An Open-label, Randomized, Parallel-group, Noninferiority Study to Evaluate the Pharmacokinetics of Bimekizumab Administered Intravenously or as a Subcutaneous Injection in Participants With Active Psoriatic Arthritis and/or Active Axial Spondyloarthritis

To demonstrate that bimekizumab administered intravenously is noninferior to subcutaneous administration.

Psoriatic ArthritisAxial Spondyloarthritis

Estimated

~$10 – $8,750

UCB Biopharma SRLNCT07290036

Observational

Expanding Access to Early Exercise Prescriptions for Underserved Patients With Axial Spondyloarthritis: A Digital Health Approach

The purpose of this study is to find out whether a mobile app called the ExerciseRx app is a practical and helpful way for people with axial spondyloarthritis …

Axial Spondyloarthritis

Estimated

~$10 – $6,250

University of WashingtonNCT07642622

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

The most clinically meaningful way to discover new targets of T cells in autoimmune diseases is to study the tissues of patients with active autoimmune disease…

Autoimmune DiseasesUlcerative ColitisMultiple Sclerosis+6 more

Estimated

~$10 – $1,050

TScan Therapeutics, Inc.NCT06587828